Recurrent Stroke Due to Metastatic Pulmonary Tumor Emboli as an Important Clinical Entity

We present an autopsy case of repetitive stroke due to tumor emboli, indistinguishable from thromboembolism with a hypercoagulable state in its clinical course. A 72-year-old man diagnosed with stage IVA oropharyngeal squamous cell carcinoma received chemoradiotherapy. Follow-up imaging revealed med...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of stroke and cerebrovascular diseases 2017-06, Vol.26 (6), p.e108-e110
Hauptverfasser: Takasugi, Junji, MD, Sakaguchi, Manabu, MD, Oyama, Naoki, MD, Gon, Yasufumi, MD, Terasaki, Yasukazu, MD, Sasaki, Tsutomu, MD, Nakahara, Susumu, MD, Ohshima, Kenji, MD, Hori, Yumiko, MD, Morii, Eiichi, MD, Mochizuki, Hideki, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e110
container_issue 6
container_start_page e108
container_title Journal of stroke and cerebrovascular diseases
container_volume 26
creator Takasugi, Junji, MD
Sakaguchi, Manabu, MD
Oyama, Naoki, MD
Gon, Yasufumi, MD
Terasaki, Yasukazu, MD
Sasaki, Tsutomu, MD
Nakahara, Susumu, MD
Ohshima, Kenji, MD
Hori, Yumiko, MD
Morii, Eiichi, MD
Mochizuki, Hideki, MD
description We present an autopsy case of repetitive stroke due to tumor emboli, indistinguishable from thromboembolism with a hypercoagulable state in its clinical course. A 72-year-old man diagnosed with stage IVA oropharyngeal squamous cell carcinoma received chemoradiotherapy. Follow-up imaging revealed mediastinal lymph nodes and pulmonary metastasis. One year later, the patient experienced right arm weakness, and brain magnetic resonance imaging showed acute ischemic lesions in multiple vascular territories. He was diagnosed with paradoxical cerebral embolism due to cancer-associated venous thrombosis and treated with rivaroxaban. However, newly developed cerebral infarcts were confirmed 1 month later. Then, rivaroxaban treatment was switched to subcutaneous unfractionated heparin injection. He was admitted again for stroke recurrence and died of respiratory failure 8 days after admission. Autopsy demonstrated pulmonary metastasis invading the veins and tumor emboli in the culprit cerebral arteries. D-dimer was kept constant at a slightly higher level, ranging from 1 to 3 µg/mL during the course of recurrence. We should consider tumor embolism in the differential diagnosis of recurrent stroke along with pulmonary tumor and resistance to heparin preparations with unchanged D-dimer levels.
doi_str_mv 10.1016/j.jstrokecerebrovasdis.2017.03.012
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1883840442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1052305717301155</els_id><sourcerecordid>1883840442</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-e32eaed16039feaa7097aaf60815d1051a52b61c67417cd60da837cee0aa23213</originalsourceid><addsrcrecordid>eNqVkUFv1DAQhS0EoqXwF5CPCCnBY6-T9IIEy9JWWtSKlgMna9aZlZwm8WI7lfbf47ALh6oX5uI5PL_R-x5j70GUIKD60JVdTMHfk6VAm-AfMLYullJAXQpVCpDP2CloJYtGAzzPu9CyUELXJ-xVjJ0QALrRL9mJbFSVR52yn9_JTiHQmPjtH2_-ZSKePP9GCWPC5Cy_mfrBjxj2_G4afOCrYeN7xzFyHPnVsPMhYf6_7N3oLPZ8NSaX9q_Ziy32kd4c3zP24-vqbnlZrK8vrpaf1oXVUqeClCSkFiqhzreEWIvzGnFbiQZ0mwMAarmpwFb1AmrbVqLFRtWWSCBKJUGdsXcH313wvyaKyQwuWup7HMlP0UDTqGYhFguZpZ8PUht8jIG2ZhfckIMZEGZGbDrzFGIzIzZCmYw4m7w93ps2A7X_LP4yzYL1QUA59YOjYKJ1NFpqXSCbTOvd_937-MjOHkHf055i56cwZr4GTJRGmNu59LlzqNXct1a_AT3zsM4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1883840442</pqid></control><display><type>article</type><title>Recurrent Stroke Due to Metastatic Pulmonary Tumor Emboli as an Important Clinical Entity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Takasugi, Junji, MD ; Sakaguchi, Manabu, MD ; Oyama, Naoki, MD ; Gon, Yasufumi, MD ; Terasaki, Yasukazu, MD ; Sasaki, Tsutomu, MD ; Nakahara, Susumu, MD ; Ohshima, Kenji, MD ; Hori, Yumiko, MD ; Morii, Eiichi, MD ; Mochizuki, Hideki, MD</creator><creatorcontrib>Takasugi, Junji, MD ; Sakaguchi, Manabu, MD ; Oyama, Naoki, MD ; Gon, Yasufumi, MD ; Terasaki, Yasukazu, MD ; Sasaki, Tsutomu, MD ; Nakahara, Susumu, MD ; Ohshima, Kenji, MD ; Hori, Yumiko, MD ; Morii, Eiichi, MD ; Mochizuki, Hideki, MD</creatorcontrib><description>We present an autopsy case of repetitive stroke due to tumor emboli, indistinguishable from thromboembolism with a hypercoagulable state in its clinical course. A 72-year-old man diagnosed with stage IVA oropharyngeal squamous cell carcinoma received chemoradiotherapy. Follow-up imaging revealed mediastinal lymph nodes and pulmonary metastasis. One year later, the patient experienced right arm weakness, and brain magnetic resonance imaging showed acute ischemic lesions in multiple vascular territories. He was diagnosed with paradoxical cerebral embolism due to cancer-associated venous thrombosis and treated with rivaroxaban. However, newly developed cerebral infarcts were confirmed 1 month later. Then, rivaroxaban treatment was switched to subcutaneous unfractionated heparin injection. He was admitted again for stroke recurrence and died of respiratory failure 8 days after admission. Autopsy demonstrated pulmonary metastasis invading the veins and tumor emboli in the culprit cerebral arteries. D-dimer was kept constant at a slightly higher level, ranging from 1 to 3 µg/mL during the course of recurrence. We should consider tumor embolism in the differential diagnosis of recurrent stroke along with pulmonary tumor and resistance to heparin preparations with unchanged D-dimer levels.</description><identifier>ISSN: 1052-3057</identifier><identifier>EISSN: 1532-8511</identifier><identifier>DOI: 10.1016/j.jstrokecerebrovasdis.2017.03.012</identifier><identifier>PMID: 28366663</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Anticoagulants - therapeutic use ; Autopsy ; Biomarkers - blood ; Biopsy ; cancer-related stroke ; Carcinoma, Squamous Cell - complications ; Carcinoma, Squamous Cell - diagnostic imaging ; Carcinoma, Squamous Cell - secondary ; Carcinoma, Squamous Cell - therapy ; Cardiovascular ; Diffusion Magnetic Resonance Imaging ; Fatal Outcome ; Fibrin Fibrinogen Degradation Products - metabolism ; Head and Neck Neoplasms - complications ; Head and Neck Neoplasms - pathology ; Head and Neck Neoplasms - therapy ; Humans ; Intracranial Embolism - diagnosis ; Intracranial Embolism - drug therapy ; Intracranial Embolism - etiology ; Lung Neoplasms - complications ; Lung Neoplasms - secondary ; Lung Neoplasms - therapy ; Lymphatic Metastasis ; Male ; Neoplasm Staging ; Neoplastic Cells, Circulating - pathology ; Neurology ; Oropharyngeal Neoplasms - complications ; Oropharyngeal Neoplasms - pathology ; Oropharyngeal Neoplasms - therapy ; pulmonary metastases ; Recurrence ; Recurrent stroke ; Respiratory Insufficiency - etiology ; Squamous Cell Carcinoma of Head and Neck ; Stroke - diagnosis ; Stroke - drug therapy ; Stroke - etiology ; Treatment Outcome ; tumor embolism</subject><ispartof>Journal of stroke and cerebrovascular diseases, 2017-06, Vol.26 (6), p.e108-e110</ispartof><rights>National Stroke Association</rights><rights>2017 National Stroke Association</rights><rights>Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-e32eaed16039feaa7097aaf60815d1051a52b61c67417cd60da837cee0aa23213</citedby><cites>FETCH-LOGICAL-c525t-e32eaed16039feaa7097aaf60815d1051a52b61c67417cd60da837cee0aa23213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1052305717301155$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28366663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takasugi, Junji, MD</creatorcontrib><creatorcontrib>Sakaguchi, Manabu, MD</creatorcontrib><creatorcontrib>Oyama, Naoki, MD</creatorcontrib><creatorcontrib>Gon, Yasufumi, MD</creatorcontrib><creatorcontrib>Terasaki, Yasukazu, MD</creatorcontrib><creatorcontrib>Sasaki, Tsutomu, MD</creatorcontrib><creatorcontrib>Nakahara, Susumu, MD</creatorcontrib><creatorcontrib>Ohshima, Kenji, MD</creatorcontrib><creatorcontrib>Hori, Yumiko, MD</creatorcontrib><creatorcontrib>Morii, Eiichi, MD</creatorcontrib><creatorcontrib>Mochizuki, Hideki, MD</creatorcontrib><title>Recurrent Stroke Due to Metastatic Pulmonary Tumor Emboli as an Important Clinical Entity</title><title>Journal of stroke and cerebrovascular diseases</title><addtitle>J Stroke Cerebrovasc Dis</addtitle><description>We present an autopsy case of repetitive stroke due to tumor emboli, indistinguishable from thromboembolism with a hypercoagulable state in its clinical course. A 72-year-old man diagnosed with stage IVA oropharyngeal squamous cell carcinoma received chemoradiotherapy. Follow-up imaging revealed mediastinal lymph nodes and pulmonary metastasis. One year later, the patient experienced right arm weakness, and brain magnetic resonance imaging showed acute ischemic lesions in multiple vascular territories. He was diagnosed with paradoxical cerebral embolism due to cancer-associated venous thrombosis and treated with rivaroxaban. However, newly developed cerebral infarcts were confirmed 1 month later. Then, rivaroxaban treatment was switched to subcutaneous unfractionated heparin injection. He was admitted again for stroke recurrence and died of respiratory failure 8 days after admission. Autopsy demonstrated pulmonary metastasis invading the veins and tumor emboli in the culprit cerebral arteries. D-dimer was kept constant at a slightly higher level, ranging from 1 to 3 µg/mL during the course of recurrence. We should consider tumor embolism in the differential diagnosis of recurrent stroke along with pulmonary tumor and resistance to heparin preparations with unchanged D-dimer levels.</description><subject>Aged</subject><subject>Anticoagulants - therapeutic use</subject><subject>Autopsy</subject><subject>Biomarkers - blood</subject><subject>Biopsy</subject><subject>cancer-related stroke</subject><subject>Carcinoma, Squamous Cell - complications</subject><subject>Carcinoma, Squamous Cell - diagnostic imaging</subject><subject>Carcinoma, Squamous Cell - secondary</subject><subject>Carcinoma, Squamous Cell - therapy</subject><subject>Cardiovascular</subject><subject>Diffusion Magnetic Resonance Imaging</subject><subject>Fatal Outcome</subject><subject>Fibrin Fibrinogen Degradation Products - metabolism</subject><subject>Head and Neck Neoplasms - complications</subject><subject>Head and Neck Neoplasms - pathology</subject><subject>Head and Neck Neoplasms - therapy</subject><subject>Humans</subject><subject>Intracranial Embolism - diagnosis</subject><subject>Intracranial Embolism - drug therapy</subject><subject>Intracranial Embolism - etiology</subject><subject>Lung Neoplasms - complications</subject><subject>Lung Neoplasms - secondary</subject><subject>Lung Neoplasms - therapy</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Neoplasm Staging</subject><subject>Neoplastic Cells, Circulating - pathology</subject><subject>Neurology</subject><subject>Oropharyngeal Neoplasms - complications</subject><subject>Oropharyngeal Neoplasms - pathology</subject><subject>Oropharyngeal Neoplasms - therapy</subject><subject>pulmonary metastases</subject><subject>Recurrence</subject><subject>Recurrent stroke</subject><subject>Respiratory Insufficiency - etiology</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><subject>Stroke - diagnosis</subject><subject>Stroke - drug therapy</subject><subject>Stroke - etiology</subject><subject>Treatment Outcome</subject><subject>tumor embolism</subject><issn>1052-3057</issn><issn>1532-8511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkUFv1DAQhS0EoqXwF5CPCCnBY6-T9IIEy9JWWtSKlgMna9aZlZwm8WI7lfbf47ALh6oX5uI5PL_R-x5j70GUIKD60JVdTMHfk6VAm-AfMLYullJAXQpVCpDP2CloJYtGAzzPu9CyUELXJ-xVjJ0QALrRL9mJbFSVR52yn9_JTiHQmPjtH2_-ZSKePP9GCWPC5Cy_mfrBjxj2_G4afOCrYeN7xzFyHPnVsPMhYf6_7N3oLPZ8NSaX9q_Ziy32kd4c3zP24-vqbnlZrK8vrpaf1oXVUqeClCSkFiqhzreEWIvzGnFbiQZ0mwMAarmpwFb1AmrbVqLFRtWWSCBKJUGdsXcH313wvyaKyQwuWup7HMlP0UDTqGYhFguZpZ8PUht8jIG2ZhfckIMZEGZGbDrzFGIzIzZCmYw4m7w93ps2A7X_LP4yzYL1QUA59YOjYKJ1NFpqXSCbTOvd_937-MjOHkHf055i56cwZr4GTJRGmNu59LlzqNXct1a_AT3zsM4</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Takasugi, Junji, MD</creator><creator>Sakaguchi, Manabu, MD</creator><creator>Oyama, Naoki, MD</creator><creator>Gon, Yasufumi, MD</creator><creator>Terasaki, Yasukazu, MD</creator><creator>Sasaki, Tsutomu, MD</creator><creator>Nakahara, Susumu, MD</creator><creator>Ohshima, Kenji, MD</creator><creator>Hori, Yumiko, MD</creator><creator>Morii, Eiichi, MD</creator><creator>Mochizuki, Hideki, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Recurrent Stroke Due to Metastatic Pulmonary Tumor Emboli as an Important Clinical Entity</title><author>Takasugi, Junji, MD ; Sakaguchi, Manabu, MD ; Oyama, Naoki, MD ; Gon, Yasufumi, MD ; Terasaki, Yasukazu, MD ; Sasaki, Tsutomu, MD ; Nakahara, Susumu, MD ; Ohshima, Kenji, MD ; Hori, Yumiko, MD ; Morii, Eiichi, MD ; Mochizuki, Hideki, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-e32eaed16039feaa7097aaf60815d1051a52b61c67417cd60da837cee0aa23213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Anticoagulants - therapeutic use</topic><topic>Autopsy</topic><topic>Biomarkers - blood</topic><topic>Biopsy</topic><topic>cancer-related stroke</topic><topic>Carcinoma, Squamous Cell - complications</topic><topic>Carcinoma, Squamous Cell - diagnostic imaging</topic><topic>Carcinoma, Squamous Cell - secondary</topic><topic>Carcinoma, Squamous Cell - therapy</topic><topic>Cardiovascular</topic><topic>Diffusion Magnetic Resonance Imaging</topic><topic>Fatal Outcome</topic><topic>Fibrin Fibrinogen Degradation Products - metabolism</topic><topic>Head and Neck Neoplasms - complications</topic><topic>Head and Neck Neoplasms - pathology</topic><topic>Head and Neck Neoplasms - therapy</topic><topic>Humans</topic><topic>Intracranial Embolism - diagnosis</topic><topic>Intracranial Embolism - drug therapy</topic><topic>Intracranial Embolism - etiology</topic><topic>Lung Neoplasms - complications</topic><topic>Lung Neoplasms - secondary</topic><topic>Lung Neoplasms - therapy</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Neoplasm Staging</topic><topic>Neoplastic Cells, Circulating - pathology</topic><topic>Neurology</topic><topic>Oropharyngeal Neoplasms - complications</topic><topic>Oropharyngeal Neoplasms - pathology</topic><topic>Oropharyngeal Neoplasms - therapy</topic><topic>pulmonary metastases</topic><topic>Recurrence</topic><topic>Recurrent stroke</topic><topic>Respiratory Insufficiency - etiology</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><topic>Stroke - diagnosis</topic><topic>Stroke - drug therapy</topic><topic>Stroke - etiology</topic><topic>Treatment Outcome</topic><topic>tumor embolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takasugi, Junji, MD</creatorcontrib><creatorcontrib>Sakaguchi, Manabu, MD</creatorcontrib><creatorcontrib>Oyama, Naoki, MD</creatorcontrib><creatorcontrib>Gon, Yasufumi, MD</creatorcontrib><creatorcontrib>Terasaki, Yasukazu, MD</creatorcontrib><creatorcontrib>Sasaki, Tsutomu, MD</creatorcontrib><creatorcontrib>Nakahara, Susumu, MD</creatorcontrib><creatorcontrib>Ohshima, Kenji, MD</creatorcontrib><creatorcontrib>Hori, Yumiko, MD</creatorcontrib><creatorcontrib>Morii, Eiichi, MD</creatorcontrib><creatorcontrib>Mochizuki, Hideki, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of stroke and cerebrovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takasugi, Junji, MD</au><au>Sakaguchi, Manabu, MD</au><au>Oyama, Naoki, MD</au><au>Gon, Yasufumi, MD</au><au>Terasaki, Yasukazu, MD</au><au>Sasaki, Tsutomu, MD</au><au>Nakahara, Susumu, MD</au><au>Ohshima, Kenji, MD</au><au>Hori, Yumiko, MD</au><au>Morii, Eiichi, MD</au><au>Mochizuki, Hideki, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recurrent Stroke Due to Metastatic Pulmonary Tumor Emboli as an Important Clinical Entity</atitle><jtitle>Journal of stroke and cerebrovascular diseases</jtitle><addtitle>J Stroke Cerebrovasc Dis</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>26</volume><issue>6</issue><spage>e108</spage><epage>e110</epage><pages>e108-e110</pages><issn>1052-3057</issn><eissn>1532-8511</eissn><abstract>We present an autopsy case of repetitive stroke due to tumor emboli, indistinguishable from thromboembolism with a hypercoagulable state in its clinical course. A 72-year-old man diagnosed with stage IVA oropharyngeal squamous cell carcinoma received chemoradiotherapy. Follow-up imaging revealed mediastinal lymph nodes and pulmonary metastasis. One year later, the patient experienced right arm weakness, and brain magnetic resonance imaging showed acute ischemic lesions in multiple vascular territories. He was diagnosed with paradoxical cerebral embolism due to cancer-associated venous thrombosis and treated with rivaroxaban. However, newly developed cerebral infarcts were confirmed 1 month later. Then, rivaroxaban treatment was switched to subcutaneous unfractionated heparin injection. He was admitted again for stroke recurrence and died of respiratory failure 8 days after admission. Autopsy demonstrated pulmonary metastasis invading the veins and tumor emboli in the culprit cerebral arteries. D-dimer was kept constant at a slightly higher level, ranging from 1 to 3 µg/mL during the course of recurrence. We should consider tumor embolism in the differential diagnosis of recurrent stroke along with pulmonary tumor and resistance to heparin preparations with unchanged D-dimer levels.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28366663</pmid><doi>10.1016/j.jstrokecerebrovasdis.2017.03.012</doi></addata></record>
fulltext fulltext
identifier ISSN: 1052-3057
ispartof Journal of stroke and cerebrovascular diseases, 2017-06, Vol.26 (6), p.e108-e110
issn 1052-3057
1532-8511
language eng
recordid cdi_proquest_miscellaneous_1883840442
source MEDLINE; Elsevier ScienceDirect Journals
subjects Aged
Anticoagulants - therapeutic use
Autopsy
Biomarkers - blood
Biopsy
cancer-related stroke
Carcinoma, Squamous Cell - complications
Carcinoma, Squamous Cell - diagnostic imaging
Carcinoma, Squamous Cell - secondary
Carcinoma, Squamous Cell - therapy
Cardiovascular
Diffusion Magnetic Resonance Imaging
Fatal Outcome
Fibrin Fibrinogen Degradation Products - metabolism
Head and Neck Neoplasms - complications
Head and Neck Neoplasms - pathology
Head and Neck Neoplasms - therapy
Humans
Intracranial Embolism - diagnosis
Intracranial Embolism - drug therapy
Intracranial Embolism - etiology
Lung Neoplasms - complications
Lung Neoplasms - secondary
Lung Neoplasms - therapy
Lymphatic Metastasis
Male
Neoplasm Staging
Neoplastic Cells, Circulating - pathology
Neurology
Oropharyngeal Neoplasms - complications
Oropharyngeal Neoplasms - pathology
Oropharyngeal Neoplasms - therapy
pulmonary metastases
Recurrence
Recurrent stroke
Respiratory Insufficiency - etiology
Squamous Cell Carcinoma of Head and Neck
Stroke - diagnosis
Stroke - drug therapy
Stroke - etiology
Treatment Outcome
tumor embolism
title Recurrent Stroke Due to Metastatic Pulmonary Tumor Emboli as an Important Clinical Entity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A48%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recurrent%20Stroke%20Due%20to%20Metastatic%20Pulmonary%20Tumor%20Emboli%20as%20an%20Important%20Clinical%20Entity&rft.jtitle=Journal%20of%20stroke%20and%20cerebrovascular%20diseases&rft.au=Takasugi,%20Junji,%20MD&rft.date=2017-06-01&rft.volume=26&rft.issue=6&rft.spage=e108&rft.epage=e110&rft.pages=e108-e110&rft.issn=1052-3057&rft.eissn=1532-8511&rft_id=info:doi/10.1016/j.jstrokecerebrovasdis.2017.03.012&rft_dat=%3Cproquest_cross%3E1883840442%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1883840442&rft_id=info:pmid/28366663&rft_els_id=1_s2_0_S1052305717301155&rfr_iscdi=true